Bertha Madras's guest appearances

Bertha Madras

The Dr. Drew Podcast

Dr. Drew Podcast

High Truths on Drugs and Addiction

Sam Quinones

Annie Duke

Laura Wasser

Dave Navarro

Erica Sandberg

Phillip Stutts

John Kelly

Chris Distefano

Ayesha Sherzai

Brendan Schaub

Fran Drescher

Nicholas Christakis

Sean Carroll

Mark Linsenmayer

Heather Monahan

OwlTail

It can be confusing…. parents tell kids not to use drugs, but we also teach that we should not stigmatize drugs… are sending mixed messages? Listen to the discussion between Dr. Lev and Harvard Professor and former ONDCP Deputy Director Dr. Bertha Madras, expert in the addicted brain.   About Dr. Bertha Madras Current position. Professor of Psychobiology, Harvard Medical School (34 years) with office based at McLean Hospital, Belmont, MA; cross-appointment at the Massachusetts General Hospital. Educated at McGill University, Montreal with post-doctoral fellowships, MIT, Cambridge, MA.  Translational Research. Addictive and therapeutic drugs: behavioral, molecular responses. Drug discovery: Novel brain probes, candidate therapeutics for neuropsychiatric disorders. Drug Policy Authorship.  Author of over 200 scientific manuscripts, articles, book chapters, co-editor of books “The Cell Biology of Addiction”, “Effects of Drug Abuse on the Human Nervous System”, “Imaging of the Human Brain in Health and Disease”   Inventions.  19 U.S. and 27 international issued patents, with collaborators  Government service and public policy. Numerous NIH committees and other advisory boards   White House, 2006-2008: Deputy Director for Demand Reduction in the White House Office of National Drug Control Policy (ONDCP), Executive Office of the President, a presidential appointment confirmed unanimously (99-0) by U.S. Senate  White House, 2017:  Appointed by the President, as one of six members of the President’s Commission on Combating Drug Addiction and the Opioid Crisis (Governors C. Christie, C. Baker, R. Cooper, Cong. P. Kennedy, AG P. Bondi). At request of Commission Chair Gov. Christie, she shepherded and wrote major portions of the final Commission report  World Health Organization: Sole author of a commissioned report, “Update of Cannabis and its Medical Use”; co-author of “The Health and Social Effects of Nonmedical Cannabis Use” U.S. Department of Justice: Sole expert witness for the U.S. Dept. of Justice in a landmark CA Federal Court decision on marijuana re-, or de-scheduling, which sustained DoJ position Vatican Pontifical Academy of Sciences, Narcotics Panel: Co-author and edited final statement  National Academy of Medicine: Current member, National Academy of Medicine Collaborative on the Opioid Crisis  Educator, Public Service   Course: Developed the first course (ABS elective) on addictions at Harvard Medical School Course: Developed first NIDA-sponsored international course on “Cell Biology of Addiction” at Cold Spring Harbor Laboratory  Museum exhibition: Project Director, PI of NIDA-sponsored grant for exhibit, CD, play at Museum of Science, Boston “Changing your Mind: Drugs in the Brain”. Disney Corp. licensed the CD. Presentations: More than 750 public and professional presentations nationally, globally  Recognition  Research Awards: NIH MERIT award, CPDD Innovator Award, Fishman Award, McLean Mendelson award, The Better World Report cited her brain imaging invention as “one of 25 technology transfer innovations (university to industry) that changed the world”  Public Service Awards: NIDA, CADCA, CPDD, Sweden, American Academy of Addiction Psychiatry Founders’ Award, others  Her experiences in research, brain biology, education, government and public service offer her a unique perspective on public policy, brain science and public education. 

It can be confusing…. parents tell kids not to use drugs, but we also teach that we should not stigmatize drugs… are sending mixed messages? Listen to the discussion between Dr. Lev and Harvard Professor and former ONDCP Deputy Director Dr. Bertha Madras, expert in the addicted brain. About Dr. Bertha Madras Current position. Professor of Psychobiology, Harvard Medical School (34 years) with office based at McLean Hospital, Belmont, MA; cross-appointment at the Massachusetts General Hospital. Educated at McGill University, Montreal with post-doctoral fellowships, MIT, Cambridge, MA.  Translational Research. Addictive and therapeutic drugs: behavioral, molecular responses. Drug discovery: Novel brain probes, candidate therapeutics for neuropsychiatric disorders. Drug Policy Authorship.  Author of over 200 scientific manuscripts, articles, book chapters, co-editor of books “The Cell Biology of Addiction”, “Effects of Drug Abuse on the Human Nervous System”, “Imaging of the Human Brain in Health and Disease”   Inventions.  19 U.S. and 27 international issued patents, with collaborators  Government service and public policy. Numerous NIH committees and other advisory boards  <ul> <li>White House, 2006-2008: Deputy Director for Demand Reduction in the White House Office of National Drug Control Policy (ONDCP), Executive Office of the President, a presidential appointment confirmed unanimously (99-0) by U.S. Senate </li> <li>White House, 2017:  Appointed by the President, as one of six members of the President’s Commission on Combating Drug Addiction and the Opioid Crisis (Governors C. Christie, C. Baker, R. Cooper, Cong. P. Kennedy, AG P. Bondi). At request of Commission Chair Gov. Christie, she shepherded and wrote major portions of the final Commission report </li> <li>World Health Organization: Sole author of a commissioned report, “Update of Cannabis and its Medical Use”; co-author of “The Health and Social Effects of Nonmedical Cannabis Use”</li> <li>U.S. Department of Justice: Sole expert witness for the U.S. Dept. of Justice in a landmark CA Federal Court decision on marijuana re-, or de-scheduling, which sustained DoJ position</li> <li>Vatican Pontifical Academy of Sciences, Narcotics Panel: Co-author and edited final statement </li> <li>National Academy of Medicine: Current member, National Academy of Medicine Collaborative on the Opioid Crisis</li> </ul> Educator, Public Service  <ul> <li>Course: Developed the first course (ABS elective) on addictions at Harvard Medical School</li> <li>Course: Developed first NIDA-sponsored international course on “Cell Biology of Addiction” at Cold Spring Harbor Laboratory </li> <li>Museum exhibition: Project Director, PI of NIDA-sponsored grant for exhibit, CD, play at Museum of Science, Boston “Changing your Mind: Drugs in the Brain”. Disney Corp. licensed the CD.</li> <li>Presentations: More than 750 public and professional presentations nationally, globally</li> </ul> Recognition <ul> <li>Research Awards: NIH MERIT award, CPDD Innovator Award, Fishman Award, McLean Mendelson award, The Better World Report cited her brain imaging invention as “one of 25 technology transfer innovations (university to industry) that changed the world” </li> <li>Public Service Awards: NIDA, CADCA, CPDD, Sweden, American Academy of Addiction Psychiatry Founders’ Award, others</li> </ul> Her experiences in research, brain biology, education, government and public service offer her a unique perspective on public policy, brain science and public education.

Episode #12 - Dr. Bertha Madras gripping discussion about the Addicted Brain

Psychobiology expert and former Deputy Director of Demand Reduction in the White House Office of National Drug Control Policy Bertha Madras joins Dr. Drew today for a conversation about drug use in America and how the medical community is focusing its efforts to try and better understand the way that our brains interact with drugs, especially when it comes to the opioid crisis in America.See omnystudio.com/listener for privacy information.

Psychobiology expert and former Deputy Director of Demand Reduction in the White House Office of National Drug Control Policy Bertha Madras joins Dr. Drew today for a conversation about drug use in America and how the medical community is focusing its efforts to try and better understand the way that our brains interact with drugs, especially when it comes to the opioid crisis in America.See <a href="https://omnystudio.com/listener" rel="nofollow" target="_blank">omnystudio.com/listener</a> for privacy information.

#329: Bertha Madras

Psychobiology expert and former Deputy Director of Demand Reduction in the White House Office of National Drug Control Policy Bertha Madras joins Dr. Drew today for a conversation about drug use in America and how the medical community is focusing its efforts to try and better understand the way that our brains interact with drugs, especially when it comes to the opioid crisis in America.